Maternal–fetal and neonatal pharmacogenomics: a review of current literature
Authors:
Open Access
- 19 November 2009
- journal article
- review article
- Published by Springer Nature in Journal of Perinatology
- Vol. 30 (9) , 571-579
Abstract
Pharmacogenomics, the study of specific genetic variations and their effect on drug response, will likely give rise to many applications in maternal–fetal and neonatal medicine; yet, an understanding of these applications in the field of obstetrics and gynecology and neonatal pediatrics is not widespread. This review describes the underpinnings of the field of pharmacogenomics and summarizes the current pharmacogenomic inquiries in relation to maternal–fetal medicine—including studies on various fetal and neonatal genetic cytochrome P450 (CYP) enzyme variants and their role in drug toxicities (for example, codeine metabolism, sepsis and selective serotonin reuptake inhibitor (SSRI) toxicity). Potential future directions, including alternative drug classification, improvements in drug efficacy and non-invasive pharmacogenomic testing, will also be explored.Keywords
This publication has 43 references indexed in Scilit:
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodProceedings of the National Academy of Sciences of the United States of America, 2008
- Pharmacogenomics: candidate gene identification, functional validation and mechanismsHuman Molecular Genetics, 2008
- Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastomaPharmacogenetics and Genomics, 2007
- Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medicationsMolecular Psychiatry, 2007
- Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm NeonatesPediatrics, 2007
- Variability of CYP2J2 Expression in Human Fetal TissuesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- The Medical Management of DepressionNew England Journal of Medicine, 2005
- Breastfeeding During Maternal Antidepressant Treatment With Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 2004
- Family studies in fetal phenytoin exposureThe Journal of Pediatrics, 1988